Literature DB >> 12401618

A mathematical model of cell salvage efficiency.

Jonathan H Waters1, Julia ShinJung Lee, Matthew T Karafa.   

Abstract

UNLABELLED: Cell salvage (CS) is one of the modalities that can be used during surgery to decrease the use of allogeneic blood. Unlike acute normovolemic hemodilution, the efficiency of CS has not been mathematically modeled. In this article, we hypothesized that a mathematical model could predict the decline of hematocrit during CS. The model that was developed accounts for both the effect of decreasing the hematocrit because of blood loss and the effect of increasing hematocrit because of the readministration of washed blood in an isovolemic patient. The efficiency of CS is defined to be the maximum allowable blood loss (MABL) for a fixed blood volume and a fixed transfusion trigger. For demonstration purposes, variables used for a hypothetical patient included an estimated blood volume of 5000 mL, a presurgery hematocrit of 45%, and a transfusion trigger of 21%. The MABL in a typical case was 9600 mL, with a CS red cell recovery rate of 60%. Patient records from a convenience sample showed an average recovery rate of 57% with 20% variability. This mathematical model suggests that CS can be a highly effective blood conservation method when red blood cell collection is optimal. IMPLICATIONS: In this study, a mathematical model of cell salvage was developed. The model was then matched against real clinical cases to gain an understanding of the variables that modify cell salvage efficiency. The model illustrates that cell salvage can be a highly effective method of avoiding blood transfusion.

Entities:  

Mesh:

Year:  2002        PMID: 12401618     DOI: 10.1097/00000539-200211000-00040

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage.

Authors:  Anthony M H Ho; Peter W Dion; Claudia A Y Cheng; Manoj K Karmakar; Gregory Cheng; Zhiyong Peng; Yu Wai Ng
Journal:  Can J Surg       Date:  2005-12       Impact factor: 2.089

2.  10 Autologous Hemotherapy.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  Red blood cell salvage analysis from clotted blood.

Authors:  Ethan K Craig; Mark H Yazer; Jonathan H Waters
Journal:  Blood Transfus       Date:  2018-04-04       Impact factor: 3.443

Review 4.  Clinical Utility of Autologous Salvaged Blood: a Review.

Authors:  Steven M Frank; Robert A Sikorski; Gerhardt Konig; Diamantis I Tsilimigras; Jan Hartmann; Mark A Popovsky; Timothy M Pawlik; Jonathan H Waters
Journal:  J Gastrointest Surg       Date:  2019-08-29       Impact factor: 3.452

5.  Clinical evaluation of a novel system for monitoring surgical hemoglobin loss.

Authors:  Allen A Holmes; Gerhardt Konig; Vicki Ting; Bridget Philip; Thomas Puzio; Siddarth Satish; Jonathan H Waters
Journal:  Anesth Analg       Date:  2014-09       Impact factor: 5.108

6.  In vitro evaluation of a novel system for monitoring surgical hemoglobin loss.

Authors:  Gerhardt Konig; Allen A Holmes; Rosario Garcia; Julianne M Mendoza; Mazyar Javidroozi; Siddarth Satish; Jonathan H Waters
Journal:  Anesth Analg       Date:  2014-09       Impact factor: 5.108

7.  A new bipolar blood sealing system embedded in perioperative strategies vs. a conventional regimen for total knee arthroplasty: results of a matched-pair study.

Authors:  Michael Pfeiffer; Heike Bräutigam; Detlev Draws; Andreas Sigg
Journal:  Ger Med Sci       Date:  2005-12-13

8.  The impact of suctioning RBCs from a simulated operative site on mechanical fragility and hemolysis.

Authors:  Jay S Raval; Jonathan H Waters; Mark H Yazer
Journal:  Korean J Hematol       Date:  2011-03-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.